New 3-O-substituted xanthone derivatives as promising acetylcholinesterase inhibitors. 2021

Zi Han Loh, and Huey Chong Kwong, and Kok Wai Lam, and Soek Sin Teh, and Gwendoline Cheng Lian Ee, and Ching Kheng Quah, and Anthony Siong Hock Ho, and Siau Hui Mah
School of Biosciences, Taylor's University, Lakeside Campus, Subang Jaya, Malaysia.

A new series of 3-O-substituted xanthone derivatives were synthesised and evaluated for their anti-cholinergic activities against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). The results indicated that the xanthone derivatives possessed good AChE inhibitory activity with eleven of them (5, 8, 11, 17, 19, 21-23, 26-28) exhibited significant effects with the IC50 values ranged 0.88 to 1.28 µM. The AChE enzyme kinetic study of 3-(4-phenylbutoxy)-9H-xanthen-9-one (23) and ethyl 2-((9-oxo-9H-xanthen-3-yl)oxy)acetate (28) showed a mixed inhibition mechanism. Molecular docking study showed that 23 binds to the active site of AChE and interacts via extensive π-π stacking with the indole and phenol side chains of Trp86 and Tyr337, besides the hydrogen bonding with the hydration site and π-π interaction with the phenol side chain of Y72. This study revealed that 3-O-alkoxyl substituted xanthone derivatives are potential lead structures, especially 23 and 28 which can be further developed into potent AChE inhibitors.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D002091 Butyrylcholinesterase An aspect of cholinesterase (EC 3.1.1.8). Pseudocholinesterase,Benzoylcholinesterase,Butyrylthiocholinesterase
D002800 Cholinesterase Inhibitors Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. Acetylcholinesterase Inhibitor,Acetylcholinesterase Inhibitors,Anti-Cholinesterase,Anticholinesterase,Anticholinesterase Agent,Anticholinesterase Agents,Anticholinesterase Drug,Cholinesterase Inhibitor,Anti-Cholinesterases,Anticholinesterase Drugs,Anticholinesterases,Cholinesterase Inhibitors, Irreversible,Cholinesterase Inhibitors, Reversible,Agent, Anticholinesterase,Agents, Anticholinesterase,Anti Cholinesterase,Anti Cholinesterases,Drug, Anticholinesterase,Drugs, Anticholinesterase,Inhibitor, Acetylcholinesterase,Inhibitor, Cholinesterase,Inhibitors, Acetylcholinesterase,Inhibitors, Cholinesterase,Inhibitors, Irreversible Cholinesterase,Inhibitors, Reversible Cholinesterase,Irreversible Cholinesterase Inhibitors,Reversible Cholinesterase Inhibitors
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004593 Electrophorus A genus of fish, in the family GYMNOTIFORMES, capable of producing an electric shock that immobilizes fish and other prey. The species Electrophorus electricus is also known as the electric eel, though it is not a true eel. Eel, Electric,Electric Eel,Electrophorus electricus
D006736 Horses Large, hoofed mammals of the family EQUIDAE. Horses are active day and night with most of the day spent seeking and consuming food. Feeding peaks occur in the early morning and late afternoon, and there are several daily periods of rest. Equus caballus,Equus przewalskii,Horse, Domestic,Domestic Horse,Domestic Horses,Horse,Horses, Domestic
D000110 Acetylcholinesterase An enzyme that catalyzes the hydrolysis of ACETYLCHOLINE to CHOLINE and acetate. In the CNS, this enzyme plays a role in the function of peripheral neuromuscular junctions. EC 3.1.1.7. Acetylcholine Hydrolase,Acetylthiocholinesterase,Hydrolase, Acetylcholine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Zi Han Loh, and Huey Chong Kwong, and Kok Wai Lam, and Soek Sin Teh, and Gwendoline Cheng Lian Ee, and Ching Kheng Quah, and Anthony Siong Hock Ho, and Siau Hui Mah
April 2002, European journal of medicinal chemistry,
Zi Han Loh, and Huey Chong Kwong, and Kok Wai Lam, and Soek Sin Teh, and Gwendoline Cheng Lian Ee, and Ching Kheng Quah, and Anthony Siong Hock Ho, and Siau Hui Mah
December 2018, Drug development research,
Zi Han Loh, and Huey Chong Kwong, and Kok Wai Lam, and Soek Sin Teh, and Gwendoline Cheng Lian Ee, and Ching Kheng Quah, and Anthony Siong Hock Ho, and Siau Hui Mah
January 2023, Natural product research,
Zi Han Loh, and Huey Chong Kwong, and Kok Wai Lam, and Soek Sin Teh, and Gwendoline Cheng Lian Ee, and Ching Kheng Quah, and Anthony Siong Hock Ho, and Siau Hui Mah
November 2021, ChemMedChem,
Zi Han Loh, and Huey Chong Kwong, and Kok Wai Lam, and Soek Sin Teh, and Gwendoline Cheng Lian Ee, and Ching Kheng Quah, and Anthony Siong Hock Ho, and Siau Hui Mah
January 2015, Bioorganic & medicinal chemistry,
Zi Han Loh, and Huey Chong Kwong, and Kok Wai Lam, and Soek Sin Teh, and Gwendoline Cheng Lian Ee, and Ching Kheng Quah, and Anthony Siong Hock Ho, and Siau Hui Mah
February 2014, Bioorganic & medicinal chemistry,
Zi Han Loh, and Huey Chong Kwong, and Kok Wai Lam, and Soek Sin Teh, and Gwendoline Cheng Lian Ee, and Ching Kheng Quah, and Anthony Siong Hock Ho, and Siau Hui Mah
November 2019, Chemical & pharmaceutical bulletin,
Zi Han Loh, and Huey Chong Kwong, and Kok Wai Lam, and Soek Sin Teh, and Gwendoline Cheng Lian Ee, and Ching Kheng Quah, and Anthony Siong Hock Ho, and Siau Hui Mah
January 2024, Bioorganic & medicinal chemistry letters,
Zi Han Loh, and Huey Chong Kwong, and Kok Wai Lam, and Soek Sin Teh, and Gwendoline Cheng Lian Ee, and Ching Kheng Quah, and Anthony Siong Hock Ho, and Siau Hui Mah
January 2006, Bioorganic & medicinal chemistry letters,
Zi Han Loh, and Huey Chong Kwong, and Kok Wai Lam, and Soek Sin Teh, and Gwendoline Cheng Lian Ee, and Ching Kheng Quah, and Anthony Siong Hock Ho, and Siau Hui Mah
June 2006, Acta pharmaceutica (Zagreb, Croatia),
Copied contents to your clipboard!